+ A
A -
dpa
New York City
Pfizer BioNTech announced on Wednesday the signing of a letter of intent with Biovac Institute Ltd, a South African biopharmaceutical company, to manufacture the Pfizer-BioNTech Covid-19 vaccine for distribution within the African Union.
Under the deal, Biovac will do manufacturing and distribution activities within Pfizer’s and BioNTech’s global Covid-19 vaccine supply chain and manufacturing network.
The companies noted that technical transfer, on-site development and equipment installation activities will begin immediately to facilitate Biovac’s involvement in the process.
New York City
Pfizer BioNTech announced on Wednesday the signing of a letter of intent with Biovac Institute Ltd, a South African biopharmaceutical company, to manufacture the Pfizer-BioNTech Covid-19 vaccine for distribution within the African Union.
Under the deal, Biovac will do manufacturing and distribution activities within Pfizer’s and BioNTech’s global Covid-19 vaccine supply chain and manufacturing network.
The companies noted that technical transfer, on-site development and equipment installation activities will begin immediately to facilitate Biovac’s involvement in the process.
